Trial NCT04486508
Publication Bikdeli B, Thromb Haemost, 2021
Primary outcome on the report: Composite of adjudicated acute VTE, arterial thrombosis, treatment with extra- corporeal membrane oxygenation (ECMO), or all-cause mortality at 90 days from enrollment

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.